Longitudinal assessment of the clinical TB score revealed that TB disease severity remained higher in anemic compared to non-anemic TB patients during the eight-week intensive-phase treatment, although blood Hb levels increased while the number of anemic TB patients decreased rapidly with effective chemotherapy. The gene discussed is GSTM1; the disease is tuberculosis.